Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis
Background Despite the goal set by WHO to eliminate hepatitis C virus (HCV) as a public
health threat, uptake of HCV testing and treatment remains low. To achieve this target …
health threat, uptake of HCV testing and treatment remains low. To achieve this target …
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: a systematic review and meta-analysis
Background With the advent of direct acting antiviral (DAA) therapies for the treatment of
hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate …
hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate …
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: the ETHOS Engage study
Background Evaluating trends in HCV treatment and prevalence is crucial for monitoring
elimination. We evaluated the change in current infection and treatment among people who …
elimination. We evaluated the change in current infection and treatment among people who …
Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—the practitioner …
Background Since the advent of interferon-free, direct-acting antiviral (DAA) therapies for
hepatitis C virus (HCV) infection, prescriber restrictions have been removed worldwide …
hepatitis C virus (HCV) infection, prescriber restrictions have been removed worldwide …
[HTML][HTML] 'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue
Introduction Long-acting injectable depot buprenorphine is a recent addition to the suite of
opioid agonist therapies (OAT) used to treat opioid use disorder (OUD). However, there has …
opioid agonist therapies (OAT) used to treat opioid use disorder (OUD). However, there has …
High satisfaction with patient-centered telemedicine for hepatitis C virus delivered to substance users: a mixed-methods study
AH Talal, EM Sofikitou, K Wang… - Telemedicine and e …, 2023 - liebertpub.com
Background: While telemedicine may increase health care access for vulnerable
populations, data are limited on whether people with opioid use disorder (PWOUD) are …
populations, data are limited on whether people with opioid use disorder (PWOUD) are …
Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all
There have been major strides towards the World Health Organization goal to eliminate
hepatitis C virus (HCV) infection as a global public health threat. The availability of simple …
hepatitis C virus (HCV) infection as a global public health threat. The availability of simple …
[HTML][HTML] Co-constructing a community-based telemedicine program for people with opioid use disorder during the COVID-19 pandemic: lessons learned and …
SB Høj, C de Montigny, S Chougar… - JMIR Public Health …, 2023 - publichealth.jmir.org
The COVID-19 pandemic triggered unprecedented expansion of telemedicine, including in
the delivery of opioid agonist treatment (OAT) for people with opioid use disorder (OUD) …
the delivery of opioid agonist treatment (OAT) for people with opioid use disorder (OUD) …
Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross‐sectional analysis
ZR Greenwald, Z Bouck, E McLean… - Journal of viral …, 2023 - Wiley Online Library
Despite the availability of publicly funded hepatitis C (HCV) treatment in Canada, treatment
gaps persist, particularly among people who inject drugs. We estimate correlates of HCV …
gaps persist, particularly among people who inject drugs. We estimate correlates of HCV …
Reducing barriers to the hepatitis C care cascade in prison via point‐of‐care RNA testing: a qualitative exploration of men in prison using an integrated framework
Abstract Background and Aims Hepatitis C virus (HCV) is highly prevalent within the prison
setting. Although HCV testing and treatment are available within prisons, system barriers …
setting. Although HCV testing and treatment are available within prisons, system barriers …